Claudio Scafoglio

Claudio Scafoglio is an Adjunct Associate Professor in the School of Medicine at the University of California Los Angeles (UCLA). His research focuses on cancer metabolism, particularly the role of glucose transporters and epigenetic regulation in lung adenocarcinoma. He employs molecular and imaging techniques to identify diagnostic biomarkers and therapeutic targets.

Education:

• MD in Molecular Pathology, Seconda Università degli Studi di Napoli (2002)
• PhD in Oncology, Seconda Università degli Studi di Napoli (2006)

Research Interests: Dr. Scafoglio investigates metabolic reprogramming in cancer, with emphasis on sodium-glucose transporters (SGLTs), glucose deprivation effects, and epigenetic modifications. His work bridges molecular biology, oncology, and translational medicine to develop strategies for early cancer detection and therapy.

Publication Trends: His recent articles (2018–2025) focus on SGLT2 inhibitors, metabolic vulnerabilities in lung cancer, and genotoxic-immune interactions. Earlier work (2006–2015) explores transcriptional regulation, DNA damage response, and developmental biology, reflecting a shift toward clinical oncology.